Final Assessment of Real-World Virological Effectiveness of Dolutegravir versus Bictegravir Triple Regimens in HIV Patients with High Viral Load: The BicDol Study in the French Dat'AIDS Cohort (BicDol)

Conference Reports for NATAP

13th IAS Conference on HIV Science
IAS 2026
July 26-31 Rio, Brazil


Final Assessment of Real-World Virological Effectiveness of Dolutegravir versus Bictegravir Triple Regimens in HIV Patients with High Viral Load: The BicDol Study in the French Dat'AIDS Cohort (BicDol) - high resolution

	IAS 2026 Rio, Brazil